Cargando…

2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas

BACKGROUND: PCR ribotyping of Clostridioides difficile strains is commonly used to describe the epidemiology of C. difficile infection (CDI). Certain ribotypes (RT) have been associated with more severe disease and clinical outcomes, such as RT 027, while others are considered less virulent, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzales-Luna, Anne J, Carlson, Travis J, Lancaster, Chris, Miranda, Julie M, Garey, Kevin W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809776/
http://dx.doi.org/10.1093/ofid/ofz360.2080
_version_ 1783462079785598976
author Gonzales-Luna, Anne J
Carlson, Travis J
Lancaster, Chris
Miranda, Julie M
Garey, Kevin W
author_facet Gonzales-Luna, Anne J
Carlson, Travis J
Lancaster, Chris
Miranda, Julie M
Garey, Kevin W
author_sort Gonzales-Luna, Anne J
collection PubMed
description BACKGROUND: PCR ribotyping of Clostridioides difficile strains is commonly used to describe the epidemiology of C. difficile infection (CDI). Certain ribotypes (RT) have been associated with more severe disease and clinical outcomes, such as RT 027, while others are considered less virulent, such as RT 014-020. Texas statewide surveillance identified the emergence of a rarely-described RT 255 beginning in 2015, which now represents the fifth most common ribotype across the state. Here we describe clinical outcomes associated with an emergent RT 255 in Texas. METHODS: A retrospective cohort study was conducted including patients from two tertiary care centers in Houston, Texas. Patients infected with C. difficile strains of either RT 255, 014-020, or 027 between 2016–18 were included. The primary outcome was disease severity as classified by the 2017 IDSA guidelines. Multivariable logistic regression analysis was done to control for other patient factors. Results were significant at P < 0.05, and all statistical analyses were completed using SPSS, version 25. RESULTS: A total of 150 patients were included (50 patients infected with each RT). Overall, 53% of the patients had severe or fulminant disease most commonly due to RT 027 (80%) followed by RT 014-020 (40%) and RT 255 (38%). Patients infected with RT 255 or 014-020 had a 75% relative reduction in the odds of severe disease compared with RT 027 after controlling for patient age and serum albumin level (OR, 0.25; 95% CI, 0.86–0.74; P = 0.12;). No differences were seen in the rates of 30- or 90-day recurrence between RTs. CONCLUSION: Although RT 255 is becoming increasingly common across Texas, it does not appear to be associated with more severe disease when compared with other common ribotypes. Further studies are warranted to determine contributing factors for its increasing prevalence. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809776
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68097762019-10-28 2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas Gonzales-Luna, Anne J Carlson, Travis J Lancaster, Chris Miranda, Julie M Garey, Kevin W Open Forum Infect Dis Abstracts BACKGROUND: PCR ribotyping of Clostridioides difficile strains is commonly used to describe the epidemiology of C. difficile infection (CDI). Certain ribotypes (RT) have been associated with more severe disease and clinical outcomes, such as RT 027, while others are considered less virulent, such as RT 014-020. Texas statewide surveillance identified the emergence of a rarely-described RT 255 beginning in 2015, which now represents the fifth most common ribotype across the state. Here we describe clinical outcomes associated with an emergent RT 255 in Texas. METHODS: A retrospective cohort study was conducted including patients from two tertiary care centers in Houston, Texas. Patients infected with C. difficile strains of either RT 255, 014-020, or 027 between 2016–18 were included. The primary outcome was disease severity as classified by the 2017 IDSA guidelines. Multivariable logistic regression analysis was done to control for other patient factors. Results were significant at P < 0.05, and all statistical analyses were completed using SPSS, version 25. RESULTS: A total of 150 patients were included (50 patients infected with each RT). Overall, 53% of the patients had severe or fulminant disease most commonly due to RT 027 (80%) followed by RT 014-020 (40%) and RT 255 (38%). Patients infected with RT 255 or 014-020 had a 75% relative reduction in the odds of severe disease compared with RT 027 after controlling for patient age and serum albumin level (OR, 0.25; 95% CI, 0.86–0.74; P = 0.12;). No differences were seen in the rates of 30- or 90-day recurrence between RTs. CONCLUSION: Although RT 255 is becoming increasingly common across Texas, it does not appear to be associated with more severe disease when compared with other common ribotypes. Further studies are warranted to determine contributing factors for its increasing prevalence. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809776/ http://dx.doi.org/10.1093/ofid/ofz360.2080 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Gonzales-Luna, Anne J
Carlson, Travis J
Lancaster, Chris
Miranda, Julie M
Garey, Kevin W
2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
title 2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
title_full 2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
title_fullStr 2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
title_full_unstemmed 2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
title_short 2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
title_sort 2402. clinical outcomes associated with an emerging clostridioides difficile ribotype 255 in texas
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809776/
http://dx.doi.org/10.1093/ofid/ofz360.2080
work_keys_str_mv AT gonzaleslunaannej 2402clinicaloutcomesassociatedwithanemergingclostridioidesdifficileribotype255intexas
AT carlsontravisj 2402clinicaloutcomesassociatedwithanemergingclostridioidesdifficileribotype255intexas
AT lancasterchris 2402clinicaloutcomesassociatedwithanemergingclostridioidesdifficileribotype255intexas
AT mirandajuliem 2402clinicaloutcomesassociatedwithanemergingclostridioidesdifficileribotype255intexas
AT gareykevinw 2402clinicaloutcomesassociatedwithanemergingclostridioidesdifficileribotype255intexas